Literature DB >> 19301152

Growth hormone production and action in N1E-115 neuroblastoma cells.

Chelsey Grimbly1, Brent Martin, Edward Karpinski, Steve Harvey.   

Abstract

Neuroblastoma cells are undifferentiated cells derived from the neural crest and are commonly used as models for studying neural function. Mouse N1E-115 neuroblastoma cells are derived from cancerous tissue and provide a model for studying the oncogenesis of neural cells. As growth hormone (GH) has been implicated as an autocrine or paracrine involved in neural regulation and in the induction or progression of cancer, the possibility that N1E-115 cells are sites of GH production and GH action was assessed. Using RT-PCR, cultured N1E-115 cells were found to express the mouse GH and GH receptor (GHR) genes. Immunocytochemistry demonstrated that both of the translated proteins (GH and its receptor) were abundantly present in the cytoplasm of these cells and their co-localization was established by confocal cytochemistry. GH action in these cells was determined in cells cultured for 72 h in the presence or absence of 10(-6) M or 10(-9) M mouse GH, which induced neurite sprouting and increased axon growth. In summary, the expression of GH and its receptor in GH responsive tumor-derived N1E-115 neuroblastoma cells suggests they provide a useful experimental model to assess GH actions in neural function or neural oncogenesis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19301152     DOI: 10.1007/s12031-009-9194-7

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  51 in total

1.  Phenotypic conversion of human mammary carcinoma cells by autocrine human growth hormone.

Authors:  Svetlana Mukhina; Hichem C Mertani; Ke Guo; Kok-Onn Lee; Peter D Gluckman; Peter E Lobie
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-07       Impact factor: 11.205

2.  Distinct neuronal growth hormone receptor ligand specificity in the rat brain.

Authors:  Tanja Anna Elisabeth Möderscheim; Larissa Joy Christophidis; Chris Edward Williams; Arjan Scheepens
Journal:  Brain Res       Date:  2006-12-20       Impact factor: 3.252

Review 3.  The oncogenic potential of growth hormone.

Authors:  Jo K Perry; B Starling Emerald; Hichem C Mertani; Peter E Lobie
Journal:  Growth Horm IGF Res       Date:  2006-11-13       Impact factor: 2.372

Review 4.  The role of growth hormone in neural development.

Authors:  Arjan Scheepens; Tanja A E Möderscheim; Peter D Gluckman
Journal:  Horm Res       Date:  2006-01-20

5.  Effect of medium serum concentration on N1E-115 neuroblastoma membrane potential development.

Authors:  W S Kisaalita; J M Bowen
Journal:  In Vitro Cell Dev Biol Anim       Date:  1997-03       Impact factor: 2.416

6.  Growth hormone and somatostatin gene expression in adult and aging rats as measured by quantitative in situ hybridization.

Authors:  M G Martinoli; J Ouellet; E Rhéaume; G Pelletier
Journal:  Neuroendocrinology       Date:  1991-12       Impact factor: 4.914

Review 7.  Neural growth hormone: an update.

Authors:  Steve Harvey; Kerry Hull
Journal:  J Mol Neurosci       Date:  2003-02       Impact factor: 3.444

8.  Growth hormone receptor synthesis and release in tumorous somatolactotrophs.

Authors:  K L Hull; E J Sanders; S Harvey
Journal:  Endocrine       Date:  1995-06       Impact factor: 3.633

Review 9.  Growth hormone in the brain: characteristics of specific brain targets for the hormone and their functional significance.

Authors:  F Nyberg
Journal:  Front Neuroendocrinol       Date:  2000-10       Impact factor: 8.606

10.  Genetic disruption of the growth hormone receptor does not influence motoneuron survival in the developing mouse.

Authors:  Sean A Parsons; Glen B Banks; Jenny A Rowland; Karen T Coschigano; John J Kopchick; Michael J Waters; Peter G Noakes
Journal:  Int J Dev Biol       Date:  2003-02       Impact factor: 2.203

View more
  5 in total

Review 1.  Actions of pituitary hormones beyond traditional targets.

Authors:  Mone Zaidi; Maria I New; Harry C Blair; Alberta Zallone; Ramkumarie Baliram; Terry F Davies; Christopher Cardozo; James Iqbal; Li Sun; Clifford J Rosen; Tony Yuen
Journal:  J Endocrinol       Date:  2018-03-19       Impact factor: 4.286

2.  Increasing antiproliferative properties of endocannabinoids in N1E-115 neuroblastoma cells through inhibition of their metabolism.

Authors:  Laurie Hamtiaux; Laurie Hansoulle; Nicolas Dauguet; Giulio G Muccioli; Bernard Gallez; Didier M Lambert
Journal:  PLoS One       Date:  2011-10-27       Impact factor: 3.240

3.  Targeting growth hormone receptor in human melanoma cells attenuates tumor progression and epithelial mesenchymal transition via suppression of multiple oncogenic pathways.

Authors:  Reetobrata Basu; Shiyong Wu; John J Kopchick
Journal:  Oncotarget       Date:  2017-03-28

Review 4.  Growth Hormone (GH) and Gonadotropin-Releasing Hormone (GnRH) in the Central Nervous System: A Potential Neurological Combinatory Therapy?

Authors:  Carlos G Martínez-Moreno; Denisse Calderón-Vallejo; Steve Harvey; Carlos Arámburo; José Luis Quintanar
Journal:  Int J Mol Sci       Date:  2018-01-26       Impact factor: 5.923

5.  Regenerative Effect of Growth Hormone (GH) in the Retina after Kainic Acid Excitotoxic Damage.

Authors:  Carlos G Martinez-Moreno; David Epardo; Jerusa E Balderas-Márquez; Thomas Fleming; Martha Carranza; Maricela Luna; Steve Harvey; Carlos Arámburo
Journal:  Int J Mol Sci       Date:  2019-09-10       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.